|
|
||||||||

* Department of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany; and
Department of Dermatology, University of Lübeck, Lübeck, Germany
The autoimmune blistering skin disease pemphigus is caused by autoantibodies against keratinocyte surface Ags. In pemphigus vulgaris (PV), autoantibodies are primarily directed against desmosomal cadherins desmoglein (Dsg) 3 and Dsg 1, whereas pemphigus foliaceus (PF) patients only have Abs against Dsg 1. At present, it is unclear whether Dsg autoantibodies contribute to pemphigus pathogenesis by direct inhibition of Dsg transinteraction. Using atomic force microscopy, we provide evidence that PV-IgG directly interfere with homophilic Dsg 3 but, similar to PF-IgG, not with homophilic Dsg 1 transinteraction, indicating that the molecular mechanisms in PV and PF pathogenesis substantially differ. PV-IgG (containing Dsg 3 or Dsg 1 and Dsg 3 autoantibodies) as well as PV-IgG Fab reduced binding activity of Dsg 3 by
60%, comparable to Ca2+ depletion. Similarly, the mouse monoclonal PV Ab AK 23 targeting the N-terminal Dsg 3 domain and AK 23 Fab reduced Dsg 3 transinteraction. In contrast, neither PV-IgG nor PF-IgG blocked Dsg 1 transinteraction. In HaCaT monolayers, however, both PV- and PF-IgG caused keratinocyte dissociation as well as loss of Dsg 1 and Dsg 3 transinteraction as revealed by laser tweezer assay. These data demonstrate that PV-IgG and PF-IgG reduce Dsg transinteraction by cell-dependent mechanisms and suggest that in addition, Abs to Dsg 3 contribute to PV by direct inhibition of Dsg transinteraction.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 487, TP B5) and the Interdisziplinäres Zentrum für Klinische Forschung Würzburg (TP A-51).
2 Address correspondence and reprint requests to Dr. Jens Waschke and Dr. Detlev Drenckhahn, Institute of Anatomy and Cell Biology, Julius-Maximilians-University, Koellikerstrasse 6, D-97070 Würzburg, Germany. E-mail addresses: jens.waschke{at}mail.uni-wuerzburg.de and anato75{at}mail.uni-wuerzburg.de
3 Abbreviations used in this paper: Dsg, desmoglein; PF, pemphigus foliaceus; PV, pemphigus vulgaris; EC, extracellular domain; AFM, atomic force microscopy; ETA, exfoliative toxin A; RT, room temperature; PEG, polyethylene glycol; Dsc, desmocollin; VE, vascular endothelial.
This article has been cited by other articles:
![]() |
V. Spindler, W.-M. Heupel, A. Efthymiadis, E. Schmidt, R. Eming, C. Rankl, P. Hinterdorfer, T. Muller, D. Drenckhahn, and J. Waschke Desmocollin 3-mediated Binding Is Crucial for Keratinocyte Cohesion and Is Impaired in Pemphigus J. Biol. Chem., October 30, 2009; 284(44): 30556 - 30564. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Delva, D. K. Tucker, and A. P. Kowalczyk The Desmosome Cold Spring Harb Perspect Biol, August 1, 2009; 1(2): a002543 - a002543. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Heupel, A. Efthymiadis, N. Schlegel, T. Muller, Y. Baumer, W. Baumgartner, D. Drenckhahn, and J. Waschke Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo J. Cell Sci., May 15, 2009; 122(10): 1616 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Heupel, T. Muller, A. Efthymiadis, E. Schmidt, D. Drenckhahn, and J. Waschke Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus J. Biol. Chem., March 27, 2009; 284(13): 8589 - 8595. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Heupel, P. Engerer, E. Schmidt, and J. Waschke Pemphigus Vulgaris IgG Cause Loss of Desmoglein-Mediated Adhesion and Keratinocyte Dissociation Independent of Epidermal Growth Factor Receptor Am. J. Pathol., February 1, 2009; 174(2): 475 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li, M. Zhao, J. Wang, Z. Liu, and L. A. Diaz Involvement of the Apoptotic Mechanism in Pemphigus Foliaceus Autoimmune Injury of the Skin J. Immunol., January 1, 2009; 182(1): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schmidt, J. Gutberlet, D. Siegmund, D. Berg, H. Wajant, and J. Waschke Apoptosis is not required for acantholysis in pemphigus vulgaris Am J Physiol Cell Physiol, January 1, 2009; 296(1): C162 - C172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |